Advanced Medical Solutions Group’s (AMS) “Buy” Rating Reiterated at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reiterated by equities researchers at Berenberg Bank in a research report issued to clients and investors on Wednesday, MarketBeat reports. They currently have a GBX 300 ($3.89) target price on the stock. Berenberg Bank’s price objective would suggest a potential upside of 46.70% from the company’s current price.

Advanced Medical Solutions Group Stock Performance

Shares of LON AMS opened at GBX 204.50 ($2.65) on Wednesday. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The business’s 50 day moving average is GBX 211.58 and its two-hundred day moving average is GBX 212.49. The company has a market cap of £441.57 million, a P/E ratio of 39.63, a P/E/G ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a 12 month low of GBX 176.60 ($2.29) and a 12 month high of GBX 275.83 ($3.58).

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.